Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mauser

Showing results (121-130 of 166) with videos related to

Pageof 17
Sort By:
Blood|September 28, 2014
Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trialPeter W Collins, Guy Young, Karin Knobe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 19, 2012
Prenatal diagnosis for haemophilia: a nationwide survey among female carriers in the NetherlandsD M W Balak, S C Gouw, I Plug, et al.
Blood|August 17, 2004
Thirty years of hemophilia treatment in the Netherlands, 1972-2001Iris Plug, Johanna G van der Bom, Marjolein Peters, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 30, 2002
Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitorsE P Mauser-Bunschoten, M M W Koopman, A D E Goede-Bolder, et al.
Blood|March 23, 2006
Bleeding in carriers of hemophiliaIris Plug, Eveline P Mauser-Bunschoten, Annette H J T Bröcker-Vriends, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 14, 2020
Managing women-specific bleeding in inherited bleeding disorders: A multidisciplinary approachEveline P Mauser-Bunschoten, Rezan A Kadir, Ellen T M Laan, et al.
Infectious Diseases and Therapy|August 5, 2018
The Impact of Hepatitis C Virus Direct-Acting Antivirals on Patient-Reported Outcomes: A Dutch Prospective Cohort StudyPatricia A M Kracht, Faydra I Lieveld, Linde M Amelung, et al.
Thrombosis Research|March 14, 2016
Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigm™4)Guy Young, Peter W Collins, Torben Colberg, et al.
Scandinavian Journal of Gastroenterology|February 24, 2001
Sustained virological response in chronic hepatitis C patients after a 6- and a 36-month interferon-alpha2b treatment schedule: a multicenter, randomized, controlled studyM Damen, C J Weegink, E P Mauser-Bunschoten, et al.
Journal of Thrombosis and Haemostasis : JTH|April 28, 2015
Inhibitor development and mortality in non-severe hemophilia AC L Eckhardt, J I Loomans, A S van Velzen, et al.
Pageof 17

Showing results (121-130 of 166) with videos related to

Sort By:
Pageof 17
Blood|September 28, 2014
Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trialPeter W Collins, Guy Young, Karin Knobe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 19, 2012
Prenatal diagnosis for haemophilia: a nationwide survey among female carriers in the NetherlandsD M W Balak, S C Gouw, I Plug, et al.
Blood|August 17, 2004
Thirty years of hemophilia treatment in the Netherlands, 1972-2001Iris Plug, Johanna G van der Bom, Marjolein Peters, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 30, 2002
Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitorsE P Mauser-Bunschoten, M M W Koopman, A D E Goede-Bolder, et al.
Blood|March 23, 2006
Bleeding in carriers of hemophiliaIris Plug, Eveline P Mauser-Bunschoten, Annette H J T Bröcker-Vriends, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 14, 2020
Managing women-specific bleeding in inherited bleeding disorders: A multidisciplinary approachEveline P Mauser-Bunschoten, Rezan A Kadir, Ellen T M Laan, et al.
Infectious Diseases and Therapy|August 5, 2018
The Impact of Hepatitis C Virus Direct-Acting Antivirals on Patient-Reported Outcomes: A Dutch Prospective Cohort StudyPatricia A M Kracht, Faydra I Lieveld, Linde M Amelung, et al.
Thrombosis Research|March 14, 2016
Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigm™4)Guy Young, Peter W Collins, Torben Colberg, et al.
Scandinavian Journal of Gastroenterology|February 24, 2001
Sustained virological response in chronic hepatitis C patients after a 6- and a 36-month interferon-alpha2b treatment schedule: a multicenter, randomized, controlled studyM Damen, C J Weegink, E P Mauser-Bunschoten, et al.
Journal of Thrombosis and Haemostasis : JTH|April 28, 2015
Inhibitor development and mortality in non-severe hemophilia AC L Eckhardt, J I Loomans, A S van Velzen, et al.
Pageof 17